SQA Chapter Webinar Series - Sponsored by RMRCSQA
Digital Pathology and Adaptive Approaches in the Regulatory Environment - Presented by Elizabeth Neyens
Digital pathology has been widely discussed for several years in societies for surgical pathologists. Recently, it’s use has increased in additional fields such as in academia for educational purposes, but also in non-clinical drug development research. In 2017, the FDA approved the first Whole Slide Imaging (WSI) system for digital pathology that allows the primary diagnosis of surgical specimens. The validation of digital pathology systems in regulated nonclinical environments remains challenging for many R&D facilities due to lack of knowledge, but also due to inefficient multidisciplinary interactions. Prospective users need to acquire digital knowledge, but also new skills in order to identify best paths of success. Intra-institutional and inter-institutional collaborations are becoming exciting disciplines with far-reaching beneficial effects.
This webinar will instruct each participant on the current status of digital pathology WSI and explain its challenges in a nonclinical GLP-driven environment. It will explain to you how to select the basic technologies, how to verify and validate current hardware/software applications, how to implement efficient new workflows with best practices, and how to overcome challenges. After having attended this webinar, you should be comfortable interacting with vendors, researchers, histologists and pathologists. You should be able to understand the crucial role of the QA department. Overall, your skills will be improved in order to react promptly and efficiently to multidisciplinary professionals in digital pathology.
Even though this event is complimentary to members, you must continue to checkout to complete your registration. After registering, you will receive further instructions on how to access the webinar via email in 1-2 business days. This online webinar will be given via WebEx.